204 related articles for article (PubMed ID: 32373210)
1. Discrete functional and mechanistic roles of chromodomain Y-like 2 (CDYL2) transcript variants in breast cancer growth and metastasis.
Yang LF; Yang F; Zhang FL; Xie YF; Hu ZX; Huang SL; Shao ZM; Li DQ
Theranostics; 2020; 10(12):5242-5258. PubMed ID: 32373210
[No Abstract] [Full Text] [Related]
2. STAT5A modulates CDYL2/SLC7A6 pathway to inhibit the proliferation and invasion of hepatocellular carcinoma by targeting to mTORC1.
Chen X; Wang Z; Zhao X; Zhang L; Zhou L; Li X; Ge C; Zhao F; Chen T; Xie H; Cui Y; Tian H; Li H; Yao M; Li J
Oncogene; 2022 Apr; 41(17):2492-2504. PubMed ID: 35314791
[TBL] [Abstract][Full Text] [Related]
3. The long non-coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2-dependent suppression of SOCS3 transcription.
Zhang KJ; Tan XL; Guo L
Mol Oncol; 2020 Feb; 14(2):309-328. PubMed ID: 31860165
[TBL] [Abstract][Full Text] [Related]
4. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
5. FBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression.
Sun R; Xie HY; Qian JX; Huang YN; Yang F; Zhang FL; Shao ZM; Li DQ
Cancer Res; 2018 Sep; 78(18):5274-5286. PubMed ID: 29945959
[TBL] [Abstract][Full Text] [Related]
6. KIF26B promotes cell proliferation and migration through the FGF2/ERK signaling pathway in breast cancer.
Teng Y; Guo B; Mu X; Liu S
Biomed Pharmacother; 2018 Dec; 108():766-773. PubMed ID: 30248545
[TBL] [Abstract][Full Text] [Related]
7. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
[TBL] [Abstract][Full Text] [Related]
8. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H
Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392
[TBL] [Abstract][Full Text] [Related]
9. Regulatory dissection of the CBX5 and hnRNPA1 bi-directional promoter in human breast cancer cells reveals novel transcript variants differentially associated with HP1α down-regulation in metastatic cells.
Vad-Nielsen J; Jakobsen KR; Daugaard TF; Thomsen R; Brügmann A; Sørensen BS; Nielsen AL
BMC Cancer; 2016 Jan; 16():32. PubMed ID: 26791953
[TBL] [Abstract][Full Text] [Related]
10. CDYL2 Epigenetically Regulates MIR124 to Control NF-κB/STAT3-Dependent Breast Cancer Cell Plasticity.
Siouda M; Dujardin AD; Barbollat-Boutrand L; Mendoza-Parra MA; Gibert B; Ouzounova M; Bouaoud J; Tonon L; Robert M; Foy JP; Lavergne V; Manie SN; Viari A; Puisieux A; Ichim G; Gronemeyer H; Saintigny P; Mulligan P
iScience; 2020 Jun; 23(6):101141. PubMed ID: 32450513
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
12. Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities.
Bemmo A; Dias C; Rose AA; Russo C; Siegel P; Majewski J
PLoS One; 2010 Aug; 5(8):e11981. PubMed ID: 20700505
[TBL] [Abstract][Full Text] [Related]
13. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.
Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY
Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222
[TBL] [Abstract][Full Text] [Related]
14. p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis.
Li SS; Xu LZ; Zhou W; Yao S; Wang CL; Xia JL; Wang HF; Kamran M; Xue XY; Dong L; Wang J; Ding XD; Bella L; Bugeon L; Xu J; Zheng FM; Dallman MJ; Lam EWF; Liu Q
Carcinogenesis; 2017 Oct; 38(11):1092-1103. PubMed ID: 28968743
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines.
Pfeffer U; Fecarotta E; Arena G; Forlani A; Vidali G
J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):99-105. PubMed ID: 8603053
[TBL] [Abstract][Full Text] [Related]
16. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.
Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM
Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration.
Papanastasiou AD; Sirinian C; Kalofonos HP
Breast Cancer Res; 2012 Jul; 14(4):R112. PubMed ID: 22824341
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
19. Lnc RNA SNHG20 participated in proliferation, invasion, and migration of breast cancer cells via miR-495.
Guan YX; Zhang MZ; Chen XZ; Zhang Q; Liu SZ; Zhang YL
J Cell Biochem; 2018 Nov; 119(10):7971-7981. PubMed ID: 29236315
[TBL] [Abstract][Full Text] [Related]
20. Amphiregulin regulates proliferation and migration of HER2-positive breast cancer cells.
Schmucker H; Blanding WM; Mook JM; Wade JF; Park JP; Kwist K; Shah H; Booth BW
Cell Oncol (Dordr); 2018 Apr; 41(2):159-168. PubMed ID: 29181633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
